Soy-Based Diets May Ease Menopausal Hot Flashes But Evidence Remains Weak
A systematic review of 15 RCTs finds soy-based diets modestly reduce hot flash frequency, but certainty of evidence is very low.
Summary
This systematic review pooled data from 15 randomized controlled trials involving nearly 2,000 menopausal women to evaluate whether dietary changes can relieve common menopausal symptoms. Soy-based dietary interventions showed a modest reduction in hot flash frequency and severity, but the overall quality of evidence was rated very low due to significant variability between studies. Other dietary patterns — including DASH, vegetarian, and MIND diets — showed some benefit for mood and cognitive function in narrative analyses, though formal meta-analysis was not possible. Flaxseed evidence was inconsistent, and data on intermittent fasting for cognition was limited. The authors conclude that dietary modification is a feasible, low-risk complement to conventional therapy, but larger, well-designed trials with standardized protocols are urgently needed before firm clinical guidance can be issued.
Detailed Summary
Menopause is a universal biological transition affecting women's quality of life, healthspan, and long-term disease risk. Declining estrogen drives vasomotor symptoms like hot flashes, alongside mood disturbances and cognitive changes — all of which intersect directly with aging trajectories. While hormone therapy remains first-line, many women seek dietary alternatives, making a rigorous synthesis of the evidence timely and clinically important.
This systematic review followed Cochrane and PRISMA methodology, searching five major databases to identify 15 randomized controlled trials enrolling 1,952 participants aged 40–65. Eligible studies focused on whole-food interventions, structured dietary patterns, or energy restriction — supplement-only trials were excluded. Risk of bias was assessed with the Cochrane RoB 2 tool, evidence certainty via GRADE, and random-effects meta-analyses were performed where data allowed.
Soy-based dietary interventions produced a statistically significant reduction in hot flash frequency and severity (SMD = -0.79; 95% CI -1.34 to -0.23) across four trials. However, effects on broader vasomotor or psychological outcomes did not reach significance. High heterogeneity (I² up to 86%) and very low GRADE certainty ratings substantially limit confidence in these findings. Narrative synthesis suggested modest cognitive and mood benefits from DASH, MIND, and lacto-ovo-vegetarian patterns, though these could not be formally meta-analyzed.
For clinicians and health-conscious women, these findings suggest that soy-rich whole foods represent a low-risk dietary strategy worth discussing during menopausal consultations — but should not be positioned as a proven therapy. The estrogen-like activity of soy isoflavones offers a plausible biological mechanism, yet the evidence base remains fragile.
Key caveats include very low certainty evidence, substantial heterogeneity, and the absence of standardized dietary protocols across trials. This summary is based on the abstract only, as the full text was not available.
Key Findings
- Soy-based diets significantly reduced hot flash frequency and severity (SMD = -0.79) across four trials.
- No significant effect of soy on overall vasomotor symptoms or psychological outcomes was demonstrated.
- DASH, MIND, and vegetarian dietary patterns showed narrative-level benefits for mood and cognition.
- Evidence certainty was rated very low across all outcomes due to heterogeneity and methodological limitations.
- Dietary modification is feasible and low-risk but cannot yet replace pharmacological therapy.
Methodology
This systematic review included 15 RCTs (n=1,952) following Cochrane and PRISMA guidelines, registered on PROSPERO (CRD42024610754). Risk of bias was assessed using the Cochrane RoB 2 tool and evidence certainty via GRADE. Random-effects meta-analyses were conducted where trial data were sufficiently homogeneous.
Study Limitations
All outcomes carried very low GRADE certainty, and meta-analyses showed high heterogeneity (I² up to 86%), limiting interpretability. The review excluded supplement-only trials, narrowing generalizability to whole-food approaches. This summary is based on the abstract only, as the full paper was not available for review.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: